Tokorozawa, Japan

Tamotsu Yamazaki


Average Co-Inventor Count = 7.7

ph-index = 3

Forward Citations = 41(Granted Patents)


Location History:

  • Tokorozawa, JP (1982 - 1983)
  • Saitama, JP (1984 - 1989)

Company Filing History:


Years Active: 1982-1989

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Tamotsu Yamazaki

Introduction

Tamotsu Yamazaki is a notable inventor based in Tokorozawa, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work focuses on developing compounds that have therapeutic applications, particularly in treating serious health conditions.

Latest Patents

Yamazaki's latest patents include novel diamine derivatives, which are compounds that exhibit strong effects for treating arrhythmias while minimizing undesirable side effects. The general formula for these compounds allows for various alkyl groups, making them versatile in their application. Additionally, he has developed an anti-peptic ulcer agent that contains aminobenzoic acid compounds, which are effective in preventing or treating peptic ulcers in humans.

Career Highlights

Tamotsu Yamazaki is currently employed at Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company. His innovative work has positioned him as a key figure in the development of new therapeutic agents. His contributions have not only advanced medical science but have also improved patient care.

Collaborations

Yamazaki has collaborated with esteemed colleagues such as Shun-Ichi Hata and Kazushige Sakai. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical products.

Conclusion

Tamotsu Yamazaki's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving health outcomes. His work continues to influence the development of effective treatments for serious medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…